Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $724.6400 (-1.28%) ($724.6400 - $724.6400) on Thu. Oct. 27, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.02% (three month average) | RSI | 52 | Latest Price | $724.6400(-1.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.5% a day on average for past five trading days. | Weekly Trend | REGN declines -0.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) DIA(34%) SPLV(30%) IWD(29%) SPY(29%) | Factors Impacting REGN price | REGN will decline at least -1.51% in a week (0% probabilities). TBT(-13%) VCSH(-2%) UUP(-2%) URA(-2%) VIXM(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.51% (StdDev 3.02%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $728.98 | 5 Day Moving Average | $731.24(-0.9%) | 10 Day Moving Average | $726.67(-0.28%) | 20 Day Moving Average | $728.98(-0.6%) | To recent high | -3.8% | To recent low | 26.3% | Market Cap | $76.833b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |